金斯瑞生物科技：CARVYKTI 第四季度产生贸易销售净额约5.55亿美元

Core Viewpoint - Kingsray Biotechnology (01548) announced that CARVYKTI is projected to generate trade sales net revenue of approximately $555 million for the quarter ending December 31, 2025, based on the collaboration and licensing agreement established with Janssen Biotech, Inc. on December 21, 2017 [1] Group 1 - Kingsray Biotechnology has entered into a collaboration and licensing agreement with Janssen Biotech, Inc. [1] - The projected trade sales net revenue for CARVYKTI is approximately $555 million for the quarter ending December 31, 2025 [1]